Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Lilly gets USFDA nod for Taltz(ixekizumab) for Pediatric Patients with Moderate to Severe Plaque Psoriasis

      Lilly gets USFDA nod for Taltz(ixekizumab) for Pediatric Patients with Moderate to Severe Plaque Psoriasis

      Medical Dialogues Bureau1 April 2020 12:30 PM IST
      Indianapolis: Eli Lilly and Company have announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License...
      Medical devices to be regulated as drugs for quality control, price monitoring: Government

      Medical devices to be regulated as drugs for quality control, price monitoring: Government

      Medical Dialogues Bureau1 April 2020 11:44 AM IST
      Delhi: All medical devices shall be regulated by the government as drugs for quality control and price monitoring from April 1, 2020, the Ministry of...
      Novalead Pharma says 42 existing drugs can help in treating coronavirus patients

      Novalead Pharma says 42 existing drugs can help in treating coronavirus patients

      Medical Dialogues Bureau1 April 2020 10:00 AM IST
      Mumbai: Novalead Pharma on Tuesday said it has found that 42 existing drugs can be helpful in treating patients at different stages of coronavirus...
      Minister Asks Pharma Companies To Contribute In PM-CARE Fund Under CSR

      Minister Asks Pharma Companies To Contribute In PM-CARE Fund Under CSR

      Medical Dialogues Bureau1 April 2020 9:30 AM IST
      Delhi: Through a recent release, D.V. Sadananda Gowda, Minister of Chemicals & Fertilizers requested all the pharmaceuticals companies to...
      US begins stockpiling malaria medicine for treating COVID-19 patients

      US begins stockpiling malaria medicine for treating COVID-19 patients

      Medical Dialogues Bureau1 April 2020 9:00 AM IST
      Washington: The US has started procuring malaria medicine 'Hydroxychloroquine' for treating COVID-19 patients as it anticipates a favorable result...
      Strides receives USFDA EIR for KRS Gardens, Bangalore facility

      Strides receives USFDA EIR for KRS Gardens, Bangalore facility

      Medical Dialogues Bureau31 March 2020 1:30 PM IST
      Bangalore: Strides Pharma Science Limited has announced that it has received the Establishment Inspection Report (EIR) for the inspection conducted by...
      Zydus gets USFDA tentative nod for  Carbidopa, Levodopa Extended-Release Capsules

      Zydus gets USFDA tentative nod for Carbidopa, Levodopa Extended-Release Capsules

      Medical Dialogues Bureau31 March 2020 1:30 PM IST
      Ahmedabad: Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules in the strengths of...
      Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; to Supply One Billion Vaccines

      Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; to Supply One Billion Vaccines

      Medical Dialogues Bureau31 March 2020 1:06 PM IST
      New Brunswick: Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since...
      AstraZeneca Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis

      AstraZeneca Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis

      Medical Dialogues Bureau31 March 2020 1:05 PM IST
      Lokelma is a highly selective, oral potassium-removing agent currently approved in the US, EU, Canada, Hong Kong, China, Russia, and Japan for the...
      South Korean coronavirus test kit makers win USFDA pre-approval

      South Korean coronavirus test kit makers win USFDA pre-approval

      Medical Dialogues Bureau30 March 2020 3:46 PM IST
      Seoul: Three Korean coronavirus test-kit makers have won preliminary approval from the U.S. Food and Drug Administration (FDA), paving the way for...
      Sanofi delays Slump Sale and transfer of Ankleshwar plant

      Sanofi delays Slump Sale and transfer of Ankleshwar plant

      Medical Dialogues Bureau30 March 2020 3:30 PM IST
      Gujrat: Sanofi has announced the change in date for the closing of a transaction relating to Slump Sale and transfer of its manufacturing facility of...
      Lupin gets USFDA EIR for Inhalation Research Center, Florida

      Lupin gets USFDA EIR for Inhalation Research Center, Florida

      Medical Dialogues Bureau30 March 2020 3:04 PM IST
      Coral Springs & Mumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S....
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok